首页> 美国卫生研究院文献>other >Current Concepts in Meniscus Tissue Engineering and Repair
【2h】

Current Concepts in Meniscus Tissue Engineering and Repair

机译:半月板组织工程和修复的最新概念

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The meniscus is the most commonly injured structure in the human knee. Meniscus deficiency has been shown to lead to advanced osteoarthritis (OA) due to abnormal mechanical forces, and replacement strategies for this structure have lagged behind other tissue engineering endeavors. The challenges include the complex three-dimensional structure with individualized size parameters, the significant compressive, tensile and shear loads encountered, and the poor blood supply. In this progress report, we provide a review of the current clinical treatments for different types of meniscal injury. We discuss the state-of-the-art research in cellular therapies and novel cell-sources for these therapies. We present the clinically available cell-free biomaterial implants and the current progress on cell-free biomaterial implants and cell-based tissue engineering strategies for the repair and replacement of meniscus, and identify the current challenges. Tissue-engineered meniscal biocomposite implants may provide an alternative solution for the treatment of meniscal injury to prevent OA in the long run, because of the limitations of the existing therapies.
机译:半月板是人类膝盖中最常见的受伤结构。半月板缺乏症已被证明由于异常的机械力而导致晚期骨关节炎(OA),并且该结构的替代策略已落后于其他组织工程学研究。挑战包括具有个性化尺寸参数的复杂三维结构,遇到的显着压缩,拉伸和剪切载荷以及血液供应不足。在此进展报告中,我们提供了针对不同类型半月板损伤的当前临床治疗方法的综述。我们讨论了细胞疗法的最新研究以及这些疗法的新型细胞来源。我们介绍了临床上可用的无细胞生物材料植入物以及无细胞生物材料植入物和基于细胞的组织工程策略在修复和置换半月板方面的最新进展,并确定了当前的挑战。由于现有疗法的局限性,组织工程化的半月板生物复合材料植入物可为半月板损伤的治疗提供替代方案,以长期预防OA。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号